Carol Vorderman 'Has Tests for 70 Cancers' in Major Health Update
Carol Vorderman has tests for 70 cancers

Television personality Carol Vorderman has shared a significant update concerning her health, revealing plans to undergo comprehensive testing for a wide range of cancers.

A New Health Mantra After Diagnosis

The Countdown legend, who is 64, explained that her approach to wellbeing has fundamentally changed since she was diagnosed with a severe case of rheumatoid arthritis almost a year ago. She described the condition as 'sudden and chronically debilitating'.

Vorderman made the announcement in a heartfelt reply to a social media post from Coronation Street actress Sally Dynevor, who is 62. Dynevor had spoken about her own decision to have a full body MRI scan to monitor her health.

Embracing Proactive Screening

On Instagram, Carol Vorderman wrote: 'Morning Sally. I've done the same this year with a full body MRI and all clear thankfully. Having the special blood test for 70 cancers this week. Early detection where possible is now my mantra.'

She acknowledged that while the costs for such private health services have decreased, they remain out of reach for many people. The presenter also opened up about the long journey to manage her rheumatoid arthritis, stating it has taken 'a long time to get the meds right'. This experience has led her to declare that she 'no longer takes my health for granted in any way'.

A Message of Prevention and Support

Sally Dynevor, who has played Sally Metcalfe on the ITV soap since 1986, replied with words of support, saying: 'So important as we get older. Sending love to you xxx'.

In her original post, Dynevor had championed a focus on 'prevention', calling it 'lifesaving'. She described her full-body MRI and CT scan as a 'powerful radiation-free way to detect potential health issues early' and a means to gain 'knowledge and peace of mind'.

Vorderman concluded her message by thanking the actress for her honesty, noting that such openness 'helps no end of us mere mortals'.